NCT00911222已完成不适用
Epidemiologic Registry for the Description of Antiemetic Strategies Under Real-life Conditions.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- iOMEDICO AG
- 入组人数
- 1,035
- 试验地点
- 1
- 主要终点
- Efficacy of anti-emetic therapies dependent on the rate "complete and major control" of nausea and emesis in moderately and highly emetogenic chemotherapy regimens.
研究概览
简要总结
The purpose of this registry is to record information on reality of anti-emetic therapies of cancer-patients in Germany. The outcome of this study is the efficacy of anti-emetic therapies dependent on the rate "complete and major control" of nausea and emesis in moderately and highly emetogenic chemotherapies, consisting of platin-derivates (cisplatin, carboplatin and oxaliplatin), anthracyclines and/or cyclophosphamid.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Moderately or highly emetogenic chemotherapy consisting of platin-derivates (cisplatin, carboplatin and oxaliplatin), anthracyclines and/or cyclophosphamid.
- •start with the 1st cycle of the regimen (chemo naive patients). Inclusion of pretreated patients is also possible, if the last treatment cycle of a previous chemotherapy was given >= 24 months ago.
- •Compliance with registry procedures
- •Age >= 18 years
- •WHO Performance Status of 0 or 1 (Karnofsky-Index >= 70%)
- •Life expectancy of at least 12 weeks
- •Signed and dated informed consent before the start of the registry
排除标准
- •Mentally incapable or incompliant patients
- •Last chemotherapy <= 24 months (if pretreated)
- •Known hypersensitivity to antiemetic medication
- •unability of the patient to be treated with oral medication
- •pregnancy or lactation period
结局指标
主要结局
Efficacy of anti-emetic therapies dependent on the rate "complete and major control" of nausea and emesis in moderately and highly emetogenic chemotherapy regimens.
时间窗: 4 chemotherapy applications per patient
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Tumor Registry of Lymphatic NeoplasiaNon-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia (CLL)Multiple Myeloma (MM)NCT00889798iOMEDICO AG3,795
已完成
不适用
Tumor Registry Pancreatic CancerPancreas CancerNCT02089269iOMEDICO AG2,325
已完成
不适用
Tumour Registry Breast CancerBreast CancerNCT01351584iOMEDICO AG4,500
已完成
不适用
Tumor Registry of Advanced Renal Cell CarcinomaRenal Cell CarcinomaNCT00610012iOMEDICO AG1,500
已完成
不适用
Clinical Tumor Anemia Registry (TAR)AnemiaNCT01795690iOMEDICO AG1,018